Your browser doesn't support javascript.
loading
Targets of chimeric antigen receptor T-cell in breast cancer and the application progress / 肿瘤研究与临床
Cancer Research and Clinic ; (6): 73-77, 2023.
Article Dans Chinois | WPRIM | ID: wpr-996189
ABSTRACT
Breast cancer is the most common malignant tumor in women. It is particularly important to seek targeted therapy other than surgery, chemoradiotherapy, endocrine therapy. With the continuous exploration of tumor immunotherapy, more and more therapeutic targets have been discovered. This paper reviews therapeutic targets of chimeric antigen receptor T-cell (CAR-T) and the application in breast cancer.

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Cancer Research and Clinic Année: 2023 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Cancer Research and Clinic Année: 2023 Type: Article